— Latest update: May 2022 —
With an ever-increasing number of bio-ventures and the establishment of a new ecosystem in the Japanese biotech field, this sector offers many opportunities for European SME companies. Through industrial, academic, government and international collaboration, various programs are being promoted and implemented. Due to Japan’s population aging and the resulting health issues, the pharmaceutical sector remains an especially attractive market, as evidenced by the high number of deals between European investors and Japanese biopharma in 2021.
How can I access the Japanese market as a novel biopharmaceutical product's owner?Japan includes a huge market for biopharmaceutical products which is open for innovative products and services, also
This website and related activities are managed by the EU-Japan Centre for Industrial Cooperation, a joint venture between the European Commission's Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) and the Japanese Government's Ministry of Economy, Trade & Industry (METI).
Hundreds of web pages with up-to-date information on Japan, more than 400 market reports and recorded webinars available as well as a lot of detailed information on Japanese business culture.